Virios Therapeutics (VIRI) Institutional Ownership → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free VIRI Stock Alerts $0.35 -0.03 (-7.87%) (As of 05/17/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Virios Therapeutics (NASDAQ:VIRI)CurrentInstitutional OwnershipPercentage9.05%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$67.40KNumber ofInstitutional Sellers(last 12 months)0 Get VIRI Insider Trade Alerts Want to know when executives and insiders are buying or selling Virios Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data VIRI Institutional Buying and Selling by Quarter Ad Banyan Hill PublishingCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Nvidia’s CEO calls it the “next amazing revolution” … and even declared it “is going to be flat out of the biggest [revolution] ever.” Jeff Bezos, Bill Gates, and Mark Zuckerberg have invested billions in it.Click on Adam's shiny forehead for more details. Virios Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/8/2023 Belvedere Trading LLC18,142$25K0.0%N/A0.099% 7/28/2023 McCollum Christoferson Group LLC30,700$42K0.0%N/A0.168% 11/7/2022 Warberg Asset Management LLC200,000$74K0.0%N/A2.401% 10/13/2022PVG Asset Management Corp80,590$31K0.1%N/A0.967% 7/12/2022 Koshinski Asset Management Inc.40,924$173K0.0%N/A0.491% 7/6/2022 Wiley BROS. Aintree Capital LLC11,000$47K0.0%N/A0.132% 5/12/2022 Cetera Advisors LLC43,944$197K0.0%+22.0%0.528% 11/16/2021 Captrust Financial Advisors40,145$212K0.0%N/A0.482% 11/16/2021 Cetera Advisors LLC48,432$256K0.0%+100.0%0.581% 11/16/2021 Masters Capital Management LLC650,000$3.44M0.1%+8.3%7.803% 11/9/2021 BlackRock Inc.15,856$84K0.0%+64.3%0.190% 9/17/2021Virtu Financial LLC13,110$82K0.0%N/A0.157% 8/13/2021 Geode Capital Management LLC18,499$116K0.0%N/A0.222% 8/13/2021 Vanguard Group Inc.141,011$887K0.0%N/A1.693% 5/18/2021 Millennium Management LLC22,858$131K0.0%+10.4%0.274% 5/17/2021 Masters Capital Management LLC600,000$3.44M0.1%+33.9%7.203% 5/14/2021PVG Asset Management Corp55,160$316K1.0%N/A0.662% 5/4/2021 Envestnet Asset Management Inc.27,844$160K0.0%N/A0.334% 2/24/2021Virtu Financial LLC35,219$264K0.0%N/A0.450% 2/17/2021 Jane Street Group LLC95,230$715K0.0%N/A1.216% (Data available from 1/1/2016 forward) VIRI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VIRI shares? During the previous two years, the following institutional investors and hedge funds held shares of Virios Therapeutics shares: Koshinski Asset Management Inc. ($173K), Warberg Asset Management LLC ($74K), Wiley BROS. Aintree Capital LLC ($47K), McCollum Christoferson Group LLC ($42K), and PVG Asset Management Corp ($31K), Belvedere Trading LLC ($25K).Learn more on VIRI's institutional investors. What percentage of Virios Therapeutics stock is owned by institutional investors? 9.05% of Virios Therapeutics stock is owned by institutional investors. Learn more on VIRI's institutional investor holdings. Which institutional investors have been buying Virios Therapeutics stock? The following institutional investors have purchased Virios Therapeutics stock in the last 24 months: Warberg Asset Management LLC ($200K), PVG Asset Management Corp ($80.59K), Koshinski Asset Management Inc. ($40.92K), McCollum Christoferson Group LLC ($30.70K), Belvedere Trading LLC ($18.14K), and Wiley BROS. Aintree Capital LLC ($11K). How much institutional buying is happening at Virios Therapeutics? Institutional investors have bought a total of 381,356 shares in the last 24 months. This purchase volume represents approximately $393.80K in transactions. Related Companies: eFFECTOR Therapeutics Major Shareholders Can-Fite BioPharma Major Shareholders Bionomics Major Shareholders Vaxxinity Major Shareholders Hepion Pharmaceuticals Major Shareholders Trevena Major Shareholders Cadrenal Therapeutics Major Shareholders Vaccinex Major Shareholders Biofrontera Major Shareholders Pulmatrix Major Shareholders This page (NASDAQ:VIRI) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceThe Presidential candidate you should REALLY be worried aboutStansberry ResearchProtect Your Bank Account Before It’s Too LateWeiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressWhat’s Really Next for America…Porter & CompanyClaim Your Complimentary Bitcoin RewardCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virios Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
